Big Money Sentiment decreased to 0.73 in 2018 Q4. It has change of 0.19, from 2018Q3’s 0.92. The ratio fall due to Genesis Energy, L.P. positioning: 16 sold and 40 reduced. 19 funds amassed positions and 22 increased positions. Investors holded 86.72 million in 2018Q3 but now own 87.54 million shares or 0.94% more.
Stephens Ar has 0.01% invested in Genesis Energy, L.P. (NYSE:GEL). Clearbridge Invests Ltd Liability Corporation accumulated 9.80M shs or 0.18% of the stock. Jpmorgan Chase And stated it has 3.86M shs or 0.02% of all its holdings. National Bank & Trust Of America Corp De reported 828,346 shs. Wells Fargo & Mn stated it has 740,136 shs or 0% of all its holdings. Perella Weinberg Prtn Capital L P invested in 106,370 shs or 0.12% of the stock. Exane Derivatives has invested 0% of its capital in Genesis Energy, L.P. (NYSE:GEL). M&T Bancorporation Corp holds 0% of its capital in Genesis Energy, L.P. (NYSE:GEL) for 14,429 shs. Us National Bank De reported 1,820 shs or 0% of all its holdings. Van Eck holds 38,265 shs or 0% of its capital. Cadence Ltd reported 0.73% of its capital in Genesis Energy, L.P. (NYSE:GEL). Oppenheimer Asset Mngmt holds 16,522 shs. Hilton Capital Ltd Liability Corp holds 0.02% in Genesis Energy, L.P. (NYSE:GEL) or 5,000 shs. Kings Point holds 0% in Genesis Energy, L.P. (NYSE:GEL) or 1,180 shs. Arrow Inv Limited Liability Com owns 19,541 shs or 0.14% of their US capital.

Genesis Energy, L.P. registered $197,500 net activity with 1 insider purchase and 0 insider sales since December 18, 2018.

Genesis Energy, L.P. (NYSE:GEL) Ratings Coverage

In total 4 analysts cover Genesis Energy (NYSE:GEL). “Buy” rating has 2, “Sell” are 0, while 2 are “Hold”. (NYSE:GEL) has 50% bullish analysts. With $29 highest and $23 lowest price target, Genesis Energy has $25.25 average price target or 8.88% above the current ($23.19) price. 7 are the (NYSE:GEL)’s ratings reports on Apr 7, 2019 according to StockzIntelligence Inc. On Wednesday, February 20 Raymond James maintained the shares of GEL in report with “Buy” rating. In Friday, October 12 report Barclays Capital maintained it with “Equal-Weight” rating and $25 target. On Thursday, February 21 the stock of Genesis Energy, L.P. (NYSE:GEL) has “Hold” rating given by Barclays Capital. On Friday, November 2 the firm earned “Outperform” rating by RBC Capital Markets. On Friday, November 2 Barclays Capital maintained Genesis Energy, L.P. (NYSE:GEL) with “Equal-Weight” rating. On Friday, November 2 the stock of Genesis Energy, L.P. (NYSE:GEL) earned “Neutral” rating by Robert W. Baird. Listed here are Genesis Energy, L.P. (NYSE:GEL) PTs and latest ratings.

21/02/2019 Broker: Barclays Capital Rating: Hold New Target: $23 Maintain
20/02/2019 Broker: Raymond James Rating: Buy New Target: $24 Maintain
20/02/2019 Broker: BidaskScore Rating: Buy Upgrade
02/11/2018 Broker: Robert W. Baird Old Rating: Neutral New Rating: Neutral Old Target: $26 New Target: $25 Maintain
02/11/2018 Broker: Barclays Capital Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $25 New Target: $24 Maintain
02/11/2018 Broker: RBC Capital Markets Old Rating: Sector Perform New Rating: Outperform New Target: $29 Upgrade
12/10/2018 Broker: Barclays Capital Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $24 New Target: $25 Maintain

Ticker’s shares touched $23.19 during the last trading session after 0.26% change.Genesis Energy, L.P. has volume of 295,098 shares. Since April 7, 2018 GEL has risen 6.47% and is uptrending. GEL outperformed the S&P 500 by 2.10%.

Genesis Energy, L.P. operates in the midstream segment of the natural gas and crude oil industry.The company has $2.84 billion market cap. It operates through four divisions: Offshore Pipeline Transportation, Refinery Services, Marine Transportation, and Supply and Logistics.Currently it has negative earnings. The Offshore Pipeline Transportation segment engages in the pipeline transportation and processing of natural gas and crude oil.

For more Genesis Energy, L.P. (NYSE:GEL) news posted recently go to: Seekingalpha.com, Investorplace.com, Prnewswire.com, Seekingalpha.com or Benzinga.com. The titles are as follows: “FDA Ad Com approaches on breast implant safety – Seeking Alpha” posted on March 21, 2019, “7 Marijuana Stocks to Play the CBD Trend – Investorplace.com” on March 22, 2019, “Bausch + Lomb Announces The US Launch Of LOTEMAX® SM (Loteprednol Etabonate Ophthalmic Gel) 0.38% For The Treatment Of Postoperative Inflammation And Pain Following Ocular Surgery – PRNewswire” with a publish date: April 02, 2019, “Genesis Energy declares $0.55 dividend – Seeking Alpha” and the last “Anheuser-Busch Inbev SA (NYSE:BUD), Compass Diversified Holdings (NYSE:CODI) – Hemp Industry Outlook: Startups, Mergers And Acquisitions Abound – Benzinga” with publication date: March 18, 2019.